| # | Drug | Count |
|---|---|---|
| 0 | BUPRENORPHINE | 29 |
| 1 | AMINOLEVULINIC ACID HYDROCHLORIDE | 17 |
| 2 | MINOXIDIL | 17 |
| 3 | MINOXIDIL FOAM 5% (WOMENS) | 15 |
| 4 | ESTRADIOL | 8 |
| 5 | FENTANYL | 5 |
| 6 | ROTIGOTINE | 5 |
| 7 | ASPIRIN | 4 |
| 8 | ASPIRIN 325 MG | 4 |
| 9 | ASPIRIN 81 MG | 4 |
| # | Drug | Count | Frequency |
|---|---|---|---|
| 0 | BERDAZIMER | 1 | 0.0105 |
| 1 | AMINOLEVULINIC ACID HYDROCHLORIDE | 17 | 0.0097 |
| 2 | KETOCONAZOLE 1% | 1 | 0.0082 |
| 3 | AVOBENZONE, HOMOSALATE, OCTISALATE, AND OCTOCRYLENE | 2 | 0.0078 |
| 4 | AVOBENZONE, HOMOSALATE, OCTISALATE, OCTOCRYLENE, AND OXYBENZONE | 1 | 0.0065 |
| 5 | TOLCAPONE | 1 | 0.0028 |
| 6 | TAPINAROF | 4 | 0.0020 |
| 7 | COLLAGENASE SANTYL | 3 | 0.0018 |
| 8 | PYRITHIONE ZINC | 1 | 0.0016 |
| 9 | MENTHOL AND METHYL SALICYLATE | 1 | 0.0015 |
| # | Drug class | Count |
|---|---|---|
| 0 | Partial Opioid Agonist [EPC] | 29 |
| 1 | Arteriolar Vasodilator [EPC] | 19 |
| 2 | 5-alpha Reductase Inhibitor [EPC] | 15 |
| 3 | Nonsteroidal Anti-inflammatory Drug [EPC] | 13 |
| 4 | Estrogen [EPC] | 12 |
| 5 | Opioid Agonist [EPC] | 7 |
| 6 | Azole Antifungal [EPC] | 6 |
| 7 | Benzodiazepine [EPC] | 6 |
| 8 | Platelet Aggregation Inhibitor [EPC] | 6 |
| 9 | Non-Standardized Chemical Allergen [EPC] | 5 |
| # | Drug class | Count | Frequency |
|---|---|---|---|
| 0 | Aryl Hydrocarbon Receptor Agonist [EPC] | 4 | 0.0020 |
| 1 | Pyrethroid [EPC] | 2 | 0.0011 |
| 2 | Nonergot Dopamine Agonist [EPC] | 5 | 0.0003 |
| 3 | Partial Opioid Agonist [EPC] | 29 | 0.0003 |
| 4 | Arteriolar Vasodilator [EPC] | 19 | 0.0002 |
| 5 | Antiparasitic [EPC] | 1 | 0.0002 |
| 6 | Pediculicide [EPC] | 1 | 0.0002 |
| 7 | Catechol-O-Methyltransferase Inhibitor [EPC] | 1 | 0.0002 |
| 8 | 5-alpha Reductase Inhibitor [EPC] | 15 | 0.0001 |
| 9 | Quinolone Antimicrobial [EPC] | 1 | 0.0001 |